Breaking News Instant updates and real-time market news.

KPTI

Karyopharm

$5.44

-0.01 (-0.18%)

10:25
04/09/19
04/09
10:25
04/09/19
10:25

Karyopharm participates in a conference call with JPMorgan

SMid Biotechnology Analyst Joseph holds a conference call with CEO Kauffman on April 9 at 11 am hosted by JPMorgan.

  • 09

    Apr

  • 06

    Jul

KPTI Karyopharm
$5.44

-0.01 (-0.18%)

03/15/19
WEDB
03/15/19
NO CHANGE
WEDB
Wedbush views Karyopharm 's PDUFA date extension as a positive
Wedbush analyst David Nierengarten maintained an Outperform rating and $6 price target on Karyopharm. In a note titled "FDA Extends PDUFA by Three Months," he said he is inclined to view the extension as a positive for the company "given the negative sentiment on the name and general belief that an April 6, 2019 approval was unlikely."
03/01/19
JPMS
03/01/19
DOWNGRADE
Target $7
JPMS
Neutral
Karyopharm downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Eric Joseph downgraded Karyopharm Therapeutics to Neutral and lowered his price target for the shares to $7 from $21. The analyst sees a "rocky regulatory road" forward for the company.
02/28/19
HCWC
02/28/19
NO CHANGE
Target $30
HCWC
Buy
H.C. Wainwright says selinexor expectations not changed by ODAC recommendation
After the FDA's Oncologic Drugs Advisory Committee, or ODAC, voted on February 26 to recommend that the FDA wait for the Phase 3 BOSTON trial results before deciding on selinexor's NDA application, H.C. Wainwright analyst Edward White noted that the decision was not unanimous and said "the FDA typically but does not always follow the ODAC panel's recommendations." It is possible that a delay to wait for the BOSTON data could push out a selinexor launch by one year or more, but the ODAC recommendation is "not changing our expectations," stated White, who keeps a Buy rating and $30 price target on shares of Karyopharm.
02/27/19
WEDB
02/27/19
NO CHANGE
Target $6
WEDB
Outperform
Karyopharm price target lowered to $6 from $14 at Wedbush
Wedbush analyst David Nierengarten lowered his price target for Karyopharm to $6 from $14 following the outcome of the FDA Advisory Committee Meeting regarding the potential approval of selinexor in penta-refractory multiple myeloma by the PDUFA date of April 6, 2019. The analyst notes that the panel voted 8 yes to 5 no to the question of "Should the approval of selinexor be delayed until results of the randomized phase 3 trial, BOSTON, are available?," as key concerns around safety, dose reductions and study design previously introduced in the published briefing docs prevailed, although the vote also indicated a receptiveness, particularly among treating physicians, for a novel drug like selinexor that could help serve this highly refractory patient population with limited treatment options. Nierengarten reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SMMF

Summit Financial Group

$26.05

-0.2 (-0.76%)

06:11
04/25/19
04/25
06:11
04/25/19
06:11
Earnings
Summit Financial Group reports Q1 EPS 56c, consensus 54c »

Net interest margin for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    May

CRR

CARBO Ceramics

$3.35

-0.01 (-0.30%)

06:11
04/25/19
04/25
06:11
04/25/19
06:11
Earnings
Breaking Earnings news story on CARBO Ceramics »

CARBO Ceramics backs FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

NOK

Nokia

$5.78

-0.015 (-0.26%)

06:10
04/25/19
04/25
06:10
04/25/19
06:10
Earnings
Nokia reports Q1 EPS (EUR 0.02) vs. EUR 0.02 last year »

Reports Q1 revenue EUR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 20

    May

PRLB

Proto Labs

$117.21

3.29 (2.89%)

06:10
04/25/19
04/25
06:10
04/25/19
06:10
Earnings
Proto Labs reports Q1 non-GAAP EPS 69, consensus 70c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 15

    May

  • 16

    May

  • 28

    May

  • 28

    May

  • 05

    Jun

CRR

CARBO Ceramics

$3.35

-0.01 (-0.30%)

06:09
04/25/19
04/25
06:09
04/25/19
06:09
Earnings
CARBO Ceramics reports Q1 EPS (73c), consensus (55c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 21

    May

XEL

Xcel Energy

$55.44

0.27 (0.49%)

06:09
04/25/19
04/25
06:09
04/25/19
06:09
Earnings
Breaking Earnings news story on Xcel Energy »

Xcel Energy backs 2019…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 15

    May

  • 21

    May

  • 17

    Jun

XCEL

EXCEL ENERGY INC.

$0.00

(0.00%)

06:08
04/25/19
04/25
06:08
04/25/19
06:08
Earnings
Excel Energy reports Q1 EPS 61c, consensus 61c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WST

West Pharmaceutical

$115.19

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
West Pharmaceutical raises FY19 adj. EPS view to $2.80-$2.90 from $2.77-$2.89 »

Consensus $2.86. Backs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Breaking Earnings news story on Iron Mountain »

Iron Mountain sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Earnings
Bombardier cuts FY19 revenue view to about $17B, consensus $16.26B »

Consolidated revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

NTB

Butterfield

$37.30

-0.18 (-0.48%)

06:07
04/25/19
04/25
06:07
04/25/19
06:07
Hot Stocks
Butterfield to acquire ABN AMRO Channel Islands for approximately $208M »

The Bank of N.T.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 29

    Apr

  • 30

    Apr

WST

West Pharmaceutical

$115.19

(0.00%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
West Pharmaceutical reports Q1 adj. EPS 74c, consensus 65c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 07

    May

ENTG

Entegris

$40.85

0.18 (0.44%)

06:06
04/25/19
04/25
06:06
04/25/19
06:06
Earnings
Entegris sees Q2 non-GAAP EPS 40c-45c, consensus48c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

WCN

Waste Connections

$89.28

0.01 (0.01%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Upgrade
Waste Connections rating change  »

Waste Connections…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 05

    May

  • 17

    May

  • 05

    Jun

BDRBF

Bombardier

$0.00

(0.00%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Bombardier sees Q1 revenue about $3.5B, consensus $4.76B »

Revenues for Q1 are…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

  • 05

    Jun

IRM

Iron Mountain

$35.84

-0.025 (-0.07%)

06:05
04/25/19
04/25
06:05
04/25/19
06:05
Earnings
Iron Mountain reports Q1 adj. EPS 17c, consensus 24c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

  • 04

    Jun

ENTG

Entegris

$40.85

0.18 (0.44%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Recommendations
Entegris analyst commentary  »

Entegris reports Q1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 30

    Apr

  • 02

    May

  • 28

    May

PTEN

Patterson-UTI

$15.13

-0.71 (-4.48%)

06:04
04/25/19
04/25
06:04
04/25/19
06:04
Earnings
Patterson-UTI reports Q1 EPS (14c), consensus (21c) »

Reports Q1 revenue $704M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 22

    May

TER

Teradyne

$47.99

3.39 (7.60%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Teradyne rating change  »

Teradyne upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    May

  • 29

    May

VMI

Valmont

$132.99

1.845 (1.41%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Upgrade
Valmont rating change  »

Valmont upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 24

    Jul

DHI

D.R. Horton

$46.67

0.275 (0.59%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
D.R. Horton sees FY19 homes closed 55,000-56,000 »

Sees FY19: Effective tax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

GRA

W.R. Grace

$75.21

-1.225 (-1.60%)

, FTI

TechnipFMC

$24.77

-0.66 (-2.60%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
W.R. Grace and TechnipFMC collaborating in high yield cracking process »

W. R. Grace (GRA) has…

GRA

W.R. Grace

$75.21

-1.225 (-1.60%)

FTI

TechnipFMC

$24.77

-0.66 (-2.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 08

    May

CUI

CUI Global

$1.17

-0.02 (-1.68%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Hot Stocks
CUI Global subsidiary secures GasPT orders from Samson »

CUI Global announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OXY

Occidental Petroleum

$62.00

-0.35 (-0.56%)

06:03
04/25/19
04/25
06:03
04/25/19
06:03
Downgrade
Occidental Petroleum rating change at Atlantic Equities »

Occidental Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

  • 07

    May

  • 10

    May

  • 29

    May

DHI

D.R. Horton

$46.67

0.275 (0.59%)

06:02
04/25/19
04/25
06:02
04/25/19
06:02
Earnings
Breaking Earnings news story on D.R. Horton »

D.R. Horton sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.